HTG Molecular Diagnostics DPO Ratio 2011-2026 | HTGM

Annual DPO Ratio HTG Molecular Diagnostics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
112	134	123	68.1	133	179	67.2	79.3	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
179	67.2	112

Quarterly DPO Ratio HTG Molecular Diagnostics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	124	110	158	-	131	143	157	-	131	126	135	-	51.6	60.5	78.3	-	136	116	172	-	204	180	113	-	61.8	74.5	80.4	-	81.8	79.2	85.3	-	116	141	67.4	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
204	51.6	115

DPO Ratio of other stocks in the Diagnostics research industry

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
BioNano Genomics BNGO	149	$ 1.14	0.44 %	$ 6.21 M	USA
Burning Rock Biotech Limited BNR	125	$ 16.07	1.39 %	$ 173 M	China
Centogene N.V. CNTG	120	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	50.1	$ 115.09	0.03 %	$ 35 B	USA
Interpace Biosciences IDXG	33	$ 2.25	-2.17 %	$ 9.95 M	USA
Aspira Women's Health AWH	189	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	56.3	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	52.5	-	0.22 %	$ 16.8 M	USA
DermTech DMTK	47.4	-	-11.32 %	$ 2.94 M	USA
CareDx, Inc CDNA	44.2	$ 16.32	1.65 %	$ 870 M	USA
Medpace Holdings MEDP	13.3	$ 498.22	0.95 %	$ 14.4 B	USA
Oxford Immunotec Global PLC OXFD	45.8	-	-	$ 562 M	Britain
Akumin AKU	21.3	-	-17.87 %	$ 25.9 M	Canada
Myriad Genetics MYGN	45.9	$ 4.45	2.3 %	$ 412 M	USA
NeoGenomics NEO	19.7	$ 7.87	2.34 %	$ 1.01 B	USA
Enzo Biochem ENZ	52.3	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	4.24 K	$ 1.4	2.19 %	$ 1.86 M	USA
Exact Sciences Corporation EXAS	49.2	-	-	$ 19.8 B	USA
Accelerate Diagnostics AXDX	125	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	52	$ 23.05	-0.35 %	$ 640 M	USA
Global Cord Blood Corporation CO	17.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	61.4	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	780	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	43.5	-	0.12 %	$ 80.1 M	China
Senseonics Holdings SENS	68	$ 6.62	-0.9 %	$ 276 M	USA
Charles River Laboratories International CRL	24.5	$ 176.51	0.49 %	$ 8.75 B	USA
PRA Health Sciences, Inc. PRAH	8.98	-	-	$ 10.7 B	USA
Soleno Therapeutics SLNO	1.44 K	$ 52.58	-0.1 %	$ 2.67 B	USA
Danaher Corporation DHR	65.4	$ 190.99	0.73 %	$ 136 B	USA
Neuronetics STIM	51.8	$ 1.37	1.11 %	$ 90.4 M	USA
Heska Corporation HSKA	39.7	-	-	$ 1.31 B	USA
Illumina ILMN	56.3	$ 122.69	1.46 %	$ 19.5 B	USA
Fulgent Genetics FLGT	34.9	$ 14.96	3.67 %	$ 452 M	USA
Thermo Fisher Scientific TMO	49.3	$ 500.25	0.83 %	$ 189 B	USA
Trinity Biotech plc TRIB	163	$ 0.69	-3.28 %	$ 61.9 M	Irlanda
Guardant Health GH	48.6	$ 79.27	0.85 %	$ 9.94 B	USA
QIAGEN N.V. QGEN	50	-	-	$ 10.6 B	Niderland
Twist Bioscience Corporation TWST	12.5	$ 48.44	1.11 %	$ 2.9 B	USA
Anixa Biosciences ANIX	1.29 K	$ 2.73	1.49 %	$ 88.6 K	USA
Biomerica BMRA	32.4	$ 2.1	-2.1 %	$ 4.82 M	USA
Invitae Corporation NVTA	69	-	-	$ 21.2 M	USA
ICON Public Limited Company ICLR	6.52	$ 107.45	0.59 %	$ 8.86 B	Irlanda
Laboratory Corporation of America Holdings LH	31.5	$ 261.12	0.07 %	$ 21.7 B	USA
Natera NTRA	17.9	$ 197.55	2.34 %	$ 19.4 B	USA
Lantheus Holdings LNTH	23.6	$ 80.41	-0.23 %	$ 5.43 B	USA
Waters Corporation WAT	102	$ 318.26	-0.54 %	$ 19 B	USA